ASCENTAGE PHARMA GROUP INTERNATIONAL: Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S. initial public offering of 7,325,000 American ...
StringersHub on MSN1h
China: Bee leaves trail on motorcycle mirror in China
On January 10, 2025, in Suzhou, located in eastern China’s Jiangsu Province, a video captured a peculiar and amusing moment ...
China sentences man behind knife attack on Japanese mother and child to death
A Chinese man who carried out a knife attack in eastern China last June that wounded a Japanese woman and her child and ...
Alleged killer of Japanese schoolboy goes on trial in China, say Japan's foreign ministry
The trial of the alleged killer of a boy enrolled in a Japanese school in Shenzhen, China began in the city on Friday, ...
China sentences man to death over attack on Japanese school bus
A Chinese man who attacked a Japanese mother and child with a knife and killed a Chinese woman who tried to protect them has ...
BioPharma Dive7h
Ascentage prices first biotech IPO of 2025, raising $126M
The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.
The Bakersfield Californian11h
Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S. initial public offering of 7,325,000 American ...
Rockville's Ascentage Pharma seeks to raise $134M in U.S. IPO
A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.
Chinese court sentences man to death over knife attack at a Japanese school bus stop
A Chinese man who injured a Japanese mother and her child and killed a Chinese bus attendant trying to protect them in a knife attack near Shanghai last June has been sentenced to death.
FiercePharma20h
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market
With the purchase of a former Lonza biologics plant now in the books, San Francisco-based CDMO Joinn Biologics is expanding from one Bay Area to another. | CDMO Joinn Biologics has completed its ...